Sign Up
NEWSROOM
We are data-driven and are focused on contributing to research and treatments for unmet medical needs
Recent News
Oct 31, 2024
Read More
Oct 28, 2024
Oct 24, 2024
Select News Releases
All News
16
Oct
INmune Bio Appoints Edgardo Baracchini to its Board of Directors, Gains Additional Licensing and Bus...
11
INmune Bio to Present at the BIO Investor 2017 Healthcare Conference...
10
INmune Bio Licenses INB03, a First-in Class Innate Immune System Check-Point Inhibitor that Targets ...
09
INmune Bio Licenses Technology to Deplete Myeloid Derived Suppressor Cells of the Innate Immune Syst...
26
Sep
INmune Bio Adds Clinical Development and Product Development Expertise with the Appointment of Tim S...
02
Mar
INmune Bio Co-Founder, Professor Mark Lowdell, Named One of Europe’s Academic-Entrepreneur Superst...
Subscribe to receive the latest updates